Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

We recently published a list of 10 Best Blue Chip Stocks to Buy for 2025. In this article, we are going to take a look at ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, ...

The CagriSema news boosted competitors, such as Eli ... that Lilly's candidate, retatrutide, which is in late-stage trials, could further erode Novo's lead. FILE PHOTO: A view shows the logo ...

The CagriSema news boosted competitors, such as Eli Lilly (LLY ... a separate note Friday that Lilly's candidate, retatrutide, which is in late-stage trials, could further erode Novo's lead. FILE ...

All-Star events, which were moved to Indianapolis in August, include community programs, entertainment and on-court ...

Cambridge, UK, 13 January 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted, Protein ...

Lilly anticipates revenue growth contributions in 2025 from new Lilly medicines such as Jaypirca ... Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on LLY: Eli Lilly NewsMORE Related ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...